ZNF529 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.518600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.610600E-01
Normal-vs-Stage2
3.399800E-01
Normal-vs-Stage3
2.271000E-01
Normal-vs-Stage4
4.253600E-01
Stage1-vs-Stage2
7.798000E-02
Stage1-vs-Stage3
6.520500E-02
Stage1-vs-Stage4
6.574200E-01
Stage2-vs-Stage3
9.563900E-02
Stage2-vs-Stage4
4.308600E-01
Stage3-vs-Stage4
2.026400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.556200E-01
Normal-vs-AfricanAmerican
3.095600E-01
Normal-vs-Asian
3.508800E-01
Caucasian-vs-AfricanAmerican
5.318600E-01
Caucasian-vs-Asian
8.648600E-01
AfricanAmerican-vs-Asian
6.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.439600E-01
Normal-vs-Female
3.648200E-01
Male-vs-Female
5.079400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.683600E-01
Normal-vs-Age(41-60Yrs)
3.862600E-01
Normal-vs-Age(61-80Yrs)
3.390800E-01
Normal-vs-Age(81-100Yrs)
2.904200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.420000E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.804200E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.278200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.774230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.041550E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.243160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.186600E-01
Normal-vs-Daily Drinker
3.061000E-01
Normal-vs-Weekly Drinker
3.255000E-01
Normal-vs-Occasional Drinker
1.731160E-01
Normal-vs-Social Drinker
3.673800E-01
Non Drinker-vs-Daily Drinker
7.866600E-01
Non Drinker-vs-Weekly Drinker
9.221400E-01
Non Drinker-vs-Occasional Drinker
1.864810E-01
Non Drinker-vs-Social Drinker
4.092800E-01
Daily Drinker-vs-Weekly Drinker
7.324000E-01
Daily Drinker-vs-Occasional Drinker
1.388600E-01
Daily Drinker-vs-Social Drinker
2.728200E-01
Weekly Drinker-vs-Occasional Drinker
2.333600E-01
Weekly Drinker-vs-Social Drinker
4.857400E-01
Occasional Drinker-vs-Social Drinker
4.714200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.458210E-01
Normal-vs-Grade 2
1.907780E-02
Normal-vs-Grade 3
2.008400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.827400E-01
Grade 1-vs-Grade 3
1.668180E-01
Grade 1-vs-Grade 4
1.458210E-01
Grade 2-vs-Grade 3
2.521600E-01
Grade 2-vs-Grade 4
1.907780E-02
Grade 3-vs-Grade 4
2.008400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.318200E-01
Normal-vs-NonDiabetic
3.495200E-01
Diabetic-vs-NonDiabetic
6.046600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.043600E-01
Normal-vs-NoPancreatitis
3.441000E-01
Pancreatitis-vs-NoPancreatitis
4.163000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.704800E-01
Normal-vs-N1
3.374200E-01
N0-vs-N1
4.099600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.380000E-01
Normal-vs-TP53-NonMutant
4.292800E-01
TP53-Mutant-vs-TP53-NonMutant
5.826100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
